乳児における水頭症のHCRN内視鏡対シャント治療 (ESTHI)
乳児における水頭症の内視鏡対シャント治療
Hydrocephalus is a potentially debilitating neurological condition that primarily affects babies under a year of age and has traditionally been treated by inserting a shunt between the brain and the abdomen. A newer endoscopic procedure offers hope of shunt- free treatment that may reduce complications over a child's life, but it is not clear if the endoscopic procedure results in similar intellectual outcome as shunt. Therefore, the investigators propose a randomized trial to compare intellectual outcome and brain structural integrity between these two treatments, to help families make the best treatment decision for their baby.
調査の概要
状態
条件
詳細な説明
The ESTHI Trial is a multi-center randomized controlled trial (RCT) comparing endoscopic third ventriculostomy with choroid plexus cauterization (ETV+CPC) and shunt in infants with hydrocephalus. The study will leverage the infrastructure of the Hydrocephalus Clinical Research Network (HCRN), a committed group of 14 leading North American pediatric neurosurgical centers with a long track-record of successful collaborative clinical research and RCTs in hydrocephalus. Optimal cognitive outcome is the primary concern of families and will, therefore, be the primary outcome. Assessment of dMRI, a validated, non-invasive method of measuring white matter microstructural integrity and structural connectivity in the developing brain, will provide further insight into the developmental consequences of these two treatments. The results of the RCT will help families determine the optimal treatment of hydrocephalus for their child.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Alabama
-
Birmingham、Alabama、アメリカ、35233
- Children's of Alabama
-
-
Arizona
-
Phoenix、Arizona、アメリカ、85016
- Phoenix Children's Hospital
-
-
California
-
Los Angeles、California、アメリカ、90027
- Children's Hospital of Los Angeles
-
-
Colorado
-
Aurora、Colorado、アメリカ、80045
- Children's Hospital Colorado
-
-
Connecticut
-
New Haven、Connecticut、アメリカ、06520
- Yale University
-
-
Florida
-
Jacksonville、Florida、アメリカ、32207
- Wolfson Children's Hospital
-
Orlando、Florida、アメリカ、32806
- Arnold Palmer Hospital for Children
-
-
Indiana
-
Indianapolis、Indiana、アメリカ、46202
- Trustees of Indiana University
-
-
Maryland
-
Baltimore、Maryland、アメリカ、21287
- Johns Hopkins Children's Center
-
-
Missouri
-
St Louis、Missouri、アメリカ、63110
- St. Louis Children's Hospital
-
-
Ohio
-
Columbus、Ohio、アメリカ、43205
- Nationwide Children's Hospital
-
-
Pennsylvania
-
Pittsburgh、Pennsylvania、アメリカ、15224
- Children's Hospital of Pittsburgh of UPMC
-
University Park、Pennsylvania、アメリカ、16802
- The Pennsylvania State University
-
-
Tennessee
-
Nashville、Tennessee、アメリカ、37232
- Monroe Carell Jr. Children's Hospital at Vanderbilt
-
-
Texas
-
Houston、Texas、アメリカ、77030
- Texas Children's Hospital
-
-
Utah
-
Salt Lake City、Utah、アメリカ、84118
- Primary Children's Hospital
-
-
Virginia
-
Richmond、Virginia、アメリカ、23284
- Virginia Commonwealth University
-
-
Washington
-
Seattle、Washington、アメリカ、98105
- Seattle Children's Hospital
-
-
-
-
Alberta
-
Calgary、Alberta、カナダ、T3B 6A8
- Alberta Children's Hospital
-
-
British Columbia
-
Vancouver、British Columbia、カナダ、V6H 3V4
- British Columbia Children's Hospital
-
-
Ontario
-
Toronto、Ontario、カナダ、M5G 1X8
- The Hospital for Sick Children
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
-
Corrected age <104 weeks and 0 days,
AND
-
Child is ≥ 37 weeks post menstrual age,
AND
-
Child must have symptomatic hydrocephalus, defined as:
Ventriculomegaly on MRI (frontal-occipital horn ratio (FOR) >0.45, which approximates "moderate ventriculomegaly"), and at least one of the following:
- Head circumference >98th percentile for corrected age with either bulging fontanelle or splayed sutures
- Upgaze paresis/palsy (sundowning)
- CSF leak
- Papilledema
- Tense pseudomeningocele or tense fluid along a track
- Vomiting or irritability, with no other attributable cause
- Bradycardias or apneas, with no other attributable cause
- Intracranial pressure (ICP) monitoring showing persistent elevation of pressure with or without plateau waves
AND
-
No prior history of shunt insertion or endoscopic third ventriculostomy (ETV) procedure (previous temporization devices and/or external ventricular drains permissible)
Exclusion Criteria:
-
Hydrocephalus due to intraventricular hemorrhage in a child born before 37 weeks gestational age; OR
-
Anatomy not suitable for ETV+CPC or anteriorly placed ventriculoperitoneal shunt defined as:
- Moderate to severe prepontine adhesions on steady state free precession (SSFP) or T2 weighted fast (turbo) spin echo (FSE/TSE) MRI, which includes the following sequences: FIESTA, FIESTA-C, TrueFISP, CISS, Balanced FFE (bFFE), CUBE, SPACE, VISTA, IsoFSE, and 3D MVOX
- Closure of one or both foramina of Monro
- Thick floor of third ventricle (≥ 3mm)
- Narrow third ventricle (<5mm)
- Presence of scalp, bone, or ventricular lesions that make placement of an anterior shunt impracticable; OR
-
Underlying condition with a high chance of mortality within 12 months; OR
-
Hydrocephalus with loculated CSF compartments; OR
-
Peritoneal cavity not suitable for distal shunt placement; OR
-
Active CSF infection; OR
-
Hydranencephaly; OR
-
Child requires an intraventricular procedure (e.g. endoscopic biopsy) in addition to the initial first-time permanent procedure for the treatment of hydrocephalus.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:ETV+CPC
Subjects randomized to this arm will undergo an ETV+CPC procedure for treatment of Hydrocephalus |
Since the early 1990s, ETV has become the main alternative to shunting for hydrocephalus. This procedure involves placing an endoscopic camera into the ventricles of the brain and creating a hole in the floor of the third ventricle to act as an internal bypass for obstructed CSF. The cauterization of choroid plexus (CPC) involves the use of a device to burn or cauterize tissue from the choroid plexus. The choroid plexus of the brain exists in the lateral ventricles, the third ventricle, and the fourth ventricle. Its main role is the production of CSF. The success of ETV alone is poor in infants, but when combined with CPC, improved results have been observed and ETV+CPC has become a safe viable option for these children. |
|
アクティブコンパレータ:Ventriculoperitoneal Shunt
Subjects randomized to this arm will undergo a Ventriculoperitoneal Shunt procedure for treatment of Hydrocephalus |
The most common treatment for hydrocephalus has been the insertion of a ventriculoperitoneal shunt, which has been in popular use for over 50 years. This consists of silastic tubing attached to a valve mechanism that runs subcutaneously from the head to the abdomen. It is one of the most common procedures performed by pediatric neurosurgeons. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Bayley Scale of Infant Development-IV (Bayley-IV) Cognitive Scale score
時間枠:12 months post randomized surgical intervention
|
The primary objective is to determine, in infants <104 weeks corrected age, with hydrocephalus requiring treatment at tertiary care pediatric neurosurgery centers in North America, if treatment with ETV+CPC compared to shunt results in non-inferior cognitive outcome at 12 months from surgery, as measured by Bayley-IV Cognitive Scale score with a non-inferiority margin of 1.5. Scaled scores range from 1-19. Higher scores indicate better outcomes. Scores will also be obtained at 3 and 5 years of age. |
12 months post randomized surgical intervention
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Bayley Scale of Infant Development-IV (Bayley-IV) Language Scaled Score
時間枠:12 months post randomized surgical intervention
|
To determine, in the same cohort of infants, if ETV+CPC compared to shunt results in non-inferior Bayley-IV Language Scaled scores. Scaled scores range from 1-19. Higher scores indicate better outcomes. |
12 months post randomized surgical intervention
|
|
Bayley Scale of Infant Development-IV (Bayley-IV) Motor Scaled Score
時間枠:12 months post randomized surgical intervention
|
To determine, in the same cohort of infants, if ETV+CPC compared to shunt results in non-inferior Bayley-IV Motor Scaled scores. Scaled scores range from 1-19. Higher scores indicate better outcomes. |
12 months post randomized surgical intervention
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Vineland-3 Communication Domain Score
時間枠:12 months post randomized surgical intervention
|
To determine, in the same cohort of infants, if ETV+CPC compared to shunt results in non-inferior Vineland-3 Communication Domain scores. Domain scores range from 20-140. Higher scores indicate better outcomes. |
12 months post randomized surgical intervention
|
|
Vineland-3 Daily Living Skills Domain Score
時間枠:12 months post randomized surgical intervention
|
To determine, in the same cohort of infants, if ETV+CPC compared to shunt results in non-inferior Vineland-3 Daily Living Skills Domain scores. Domain scores range from 20-140. Higher scores indicate better outcomes. |
12 months post randomized surgical intervention
|
|
Vineland-3 Socialization Domain Score
時間枠:12 months post randomized surgical intervention
|
To determine, in the same cohort of infants, if ETV+CPC compared to shunt results in non-inferior Vineland-3 Socialization Domain scores. Domain scores range from 20-140. Higher scores indicate better outcomes. |
12 months post randomized surgical intervention
|
|
Vineland-3 Motor Skills Domain Score
時間枠:12 months post randomized surgical intervention
|
To determine, in the same cohort of infants, if ETV+CPC compared to shunt results in non-inferior Vineland-3 Motor Skills Domain scores. Domain scores range from 20-140. Higher scores indicate better outcomes. |
12 months post randomized surgical intervention
|
|
Vineland-3 Adaptive Behavior Composite Score
時間枠:12 months post randomized surgical intervention
|
To determine, in the same cohort of infants, if ETV+CPC compared to shunt results in non-inferior Vineland-3 Adaptive Behavior Composite (ABC) scores. ABC scores range from 20-140. Higher scores indicate better outcomes. |
12 months post randomized surgical intervention
|
|
The occurrence of treatment failure.
時間枠:Through study completion, a maximum of 7 years.
|
Treatment failure is defined as obstruction, loculated compartments, overdrainage, CSF infection, or significant intraoperative complication. The rate of occurrence of each type, for the initial procedure, will be calculated. Failure can be captured at anytime during the course of the 7 year study. Occurrence between treatment arms will be compared. |
Through study completion, a maximum of 7 years.
|
|
Time to failure.
時間枠:Through study completion, a maximum of 7 years
|
Time to failure is the number of days in which the intervention is functionally successful. It is calculated from date of surgery to date of failure, as described in Outcome 9. Time to failure between treatment arms will be compared. |
Through study completion, a maximum of 7 years
|
|
Total number of hospital admission days within 12 months after surgery
時間枠:12 months post randomized surgical intervention
|
Number of days subject is admitted to the hospital during the first 12 months following the initial surgical intervention. All hospital admissions included, regardless of reason for admission. Number of hospital admission days between treatment arms will be compared. |
12 months post randomized surgical intervention
|
|
Total number of repeat surgeries within 12 months after surgery
時間枠:12 months post randomized surgical intervention
|
Number of shunt and ETV+CPC procedures during the first 12 months following the initial surgical intervention. Number of repeat surgeries between treatment arms will be compared. |
12 months post randomized surgical intervention
|
|
Total number of brain imaging (CT, MRI, ultrasound) scans within 12 months after surgery
時間枠:12 months post randomized surgical intervention
|
Number of CT, MRI, and ultrasound brain scans during the first 12 months following the initial surgical intervention. Total imaging between treatment arms will be compared. |
12 months post randomized surgical intervention
|
|
All major peri-operative and post-operative complications
時間枠:Through study completion, a maximum of 7 years
|
Number of peri-operative and post-operative complications to include those related to CSF circulation, infection, hemorrhage, seizures, and new neurological deficits. Number of complications between treatment arms will be compared. |
Through study completion, a maximum of 7 years
|
|
Brain and ventricle volume on MRI performed at 12 months after surgery
時間枠:12 months post randomized surgical intervention
|
Brain and CSF volumes will be converted to Z-scores based on previously described age- and sex-adjusted distributions and used for comparison of brain volume and growth between ETV+CPC and shunt treatment groups. |
12 months post randomized surgical intervention
|
|
dMRI corpus collosum (CC) and corticospinal tract (CST) fractional anisotropy (FA) at 12 months after surgery.
時間枠:12 months post randomized surgical intervention
|
Develop dMRI maps, including fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD). Tract-based spatial statistics (TBSS) will be used for voxel-wise analyses of white matter tracts. Maps will be used to compare cerebral structural connectivity between the two treatment arms. |
12 months post randomized surgical intervention
|
|
Cerebral spinal fluid myelin basic protein (MBP) levels measured at the time of ETV+CPC or shunt
時間枠:12 months post randomized surgical intervention
|
Examine correlations of cerebral spinal fluid myelin basic protein (MBP) levels to post-operative Bayley-IV Cognitive Scale score. |
12 months post randomized surgical intervention
|
|
Cerebral spinal fluid amyloid precursor protein (APP) levels measured at the time of ETV+CPC or shunt
時間枠:12 months post randomized surgical intervention
|
Examine correlations of cerebral spinal fluid amyloid precursor protein (APP) to post-operative Bayley-IV Cognitive Scale score |
12 months post randomized surgical intervention
|
|
Cerebral spinal fluid NCAM-1 levels measured at the time of ETV+CPC or shunt
時間枠:12 months post randomized surgical intervention
|
Examine correlations of cerebral spinal fluid NCAM-1 levels to post-operative Bayley-IV Cognitive Scale score |
12 months post randomized surgical intervention
|
|
Cerebral spinal fluid glial fibrillary acid protein (GFAP) levels measured at the time of ETV+CPC or shunt
時間枠:12 months post randomized surgical intervention
|
Examine correlations of cerebral spinal fluid glial fibrillary acid protein (GFAP) to post-operative Bayley-IV Cognitive Scale score |
12 months post randomized surgical intervention
|
|
Wechsler Preschool & Primary Scale of Intelligence (WPPSI) Scores
時間枠:At 5 years of age
|
To determine, in infants who reach 5 years of age before the end of the study, if ETV+CPC compared to shunt results in non-inferior WPPSI scaled scores. Scaled scores range from 1-19. Higher scores indicate better outcomes. |
At 5 years of age
|
|
Health related quality of life (HRQoL) measurements
時間枠:12 months post randomized surgical intervention, and at 3 and 5 years of age
|
To compare health-related quality of life (HRQoL), as measured by vi-sual analogue scales (VAS), Health Utilities Preschool (HuPS), and the Hydrocephalus Outcome Questionnaire (HOQ), between treatment arms. |
12 months post randomized surgical intervention, and at 3 and 5 years of age
|
協力者と研究者
スポンサー
協力者
捜査官
- スタディチェア:John Kestle, MD、University of Utah
- 主任研究者:Abhaya Kulkarni, MD、University of Toronto
- 主任研究者:David Limbrick, MD、Washington University School of Medicine
- 主任研究者:Richard Holubkov, PhD、University of Utah
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- HCRN 012
- 1U01NS107486-01A1 (米国 NIH グラント/契約)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
After subject enrollment and 5 year follow up have been completed, we will prepare a final study database for analysis. A releasable database will be produced and completely de-identified in accordance with the definitions provided in the Health insurance Portability and Accountability Act (HIPAA). Namely, all identifiers specified in HIPAA will be recoded in a manner that will make it impossible to deduce or impute the specific identity of any patient. The database will not contain any institutional identifiers. We will also prepare a data dictionary that provides a concise definition of every data element included in the database. If specific data elements have idiosyncrasies that might affect interpretation or analysis, this will be discussed in the dictionary document.
In accordance with policies determined by the investigators and funding sponsors, the releasable database will be provided to users in electronic form.
IPD 共有時間枠
Within one year of primary publication or within 18 months of the last study visit of the last subject, whichever occurs first.
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- SAP
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。